Release Details
EXL Reports 2019 Fourth Quarter and Full Year Results
2019 Fourth Quarter Revenues of
Q4 Diluted EPS (GAAP) of
Q4 Adjusted Diluted EPS (Non-GAAP) of
2019 Revenues of
2019 Diluted EPS (GAAP) of
2019 Adjusted Diluted EPS (Non-GAAP) of
“Our success is a result of our ability to deliver tangible business outcomes for our clients as their strategic digital transformation partner. Our ability to combine deep domain expertise, data, analytics and digital technologies to orchestrate solutions for business problems has positioned us as a market leader and a partner of choice. Our pipeline remains strong and we look forward to the continued growth in 2020.”
______________________________________________________________
(1) Refer to Financial Highlights for details.
Financial Highlights: Fourth Quarter 2019
We have six reportable segments: Insurance, Healthcare, Travel, Transportation & Logistics, Finance & Accounting, All Other (consisting of our Banking & Financial Services, Utilities and Consulting operating segments) and Analytics. Reconciliations of adjusted (non-GAAP) financial measures to GAAP measures are included at the end of this release.
- Revenues for the quarter ended
December 31, 2019 increased to$256.9 million compared to$234.9 million for the fourth quarter of 2018, an increase of 9.4% on a reported basis and 9.3% on a constant currency basis from the fourth quarter of 2018, as well as an increase of 2.2% sequentially on a reported basis and 2.0% on a constant currency basis, from the third quarter of 2019.
Revenues | Gross Margin | ||||||||||||||||||||
Three months ended | Three months ended | ||||||||||||||||||||
Reportable Segments | 2019 | 2018 | 2019 | 2019 | 2018 | 2019 | |||||||||||||||
(dollars in millions) | |||||||||||||||||||||
Insurance | $ | 75.2 | $ | 65.1 | $ | 77.7 | 31.4 | % | 31.0 | % | 33.7 | % | |||||||||
Healthcare | 26.0 | 21.4 | 24.0 | 21.6 | % | 20.5 | % | 19.1 | % | ||||||||||||
Travel, Transportation & Logistics | 16.1 | 16.9 | 17.0 | 43.2 | % | 40.6 | % | 42.2 | % | ||||||||||||
Finance & Accounting | 27.9 | 25.2 | 26.5 | 41.2 | % | 40.7 | % | 37.3 | % | ||||||||||||
All Other | 18.0 | 20.4 | 17.4 | 35.1 | % | 32.5 | % | 29.1 | % | ||||||||||||
Analytics | 93.7 | 85.9 | 88.8 | 37.0 | % | 36.8 | % | 34.8 | % | ||||||||||||
Total revenues, net | $ | 256.9 | $ | 234.9 | $ | 251.4 | 34.5 | % | 34.0 | % | 33.4 | % |
- Operating income margin for the quarter ended
December 31, 2019 was 9.1%, compared to an operating loss margin of 0.9% for the fourth quarter of 2018 and operating income margin of 8.9% for the third quarter of 2019. During the quarters endedDecember 31, 2019 and 2018 andSeptember 30, 2019 , we recorded impairment and restructuring charges of$1.4 million ,$20.1 million and$0.5 million , respectively, related to the wind down of the Health Integrated business, which reduced our operating income margin by approximately 50 basis points, 850 basis points and 20 basis points, respectively. The wind down of the Health Integrated business was substantially completed onDecember 31, 2019 and we do not expect to incur impairment and restructuring charges in 2020. Adjusted operating income margin for the quarter endedDecember 31, 2019 was 13.3% compared to 13.1% for the fourth quarter of 2018 and 14.3% for the third quarter of 2019.
- Diluted earnings per share for the quarter ended
December 31, 2019 was$0.62 compared to$0.11 for the fourth quarter of 2018 and$0.55 for the third quarter of 2019. During the quarters endedDecember 31, 2019 and 2018 andSeptember 30, 2019 , we recorded impairment and restructuring charges of$1.4 million ($1.0 million net of tax),$20.1 million ($17.0 million net of tax) and$0.5 million ($0.4 million net of tax), respectively, related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by$0.03 ,$0.49 and$0.01 , respectively. Adjusted diluted earnings per share for the quarter endedDecember 31, 2019 was$0.79 compared to$0.74 for the fourth quarter of 2018 and$0.84 for the third quarter of 2019.
Financial Highlights: Full Year 2019
- Revenues for the year ended
December 31, 2019 increased to$991.3 million compared to$883.1 million for the year endedDecember 31, 2018 , an increase of 12.3% on a reported basis and 13.0% on a constant currency basis.
Revenues | Gross Margin | |||||||||||||
Year ended | Year ended | |||||||||||||
Reportable Segments | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2018 | ||||||||||
(dollars in millions) | ||||||||||||||
Insurance | $ | 294.2 | $ | 258.1 | 32.1 | % | 32.2 | % | ||||||
Healthcare | 90.6 | 84.4 | 18.7 | % | 20.9 | % | ||||||||
Travel, Transportation & Logistics | 68.0 | 70.2 | 43.0 | % | 41.5 | % | ||||||||
Finance & Accounting | 106.6 | 97.9 | 40.6 | % | 39.6 | % | ||||||||
All Other | 74.6 | 87.2 | 34.6 | % | 33.0 | % | ||||||||
Analytics | 357.3 | 285.3 | 35.3 | % | 35.3 | % | ||||||||
Total revenues, net | $ | 991.3 | $ | 883.1 | 33.9 | % | 33.8 | % |
- Operating income margin for the year ended
December 31, 2019 was 7.7% compared to 5.6% for the year endedDecember 31, 2018 . During the year 2019 and 2018, we recorded impairment and restructuring charges of$8.7 million and$20.1 million , respectively, related to the wind down of the Health Integrated business, which reduced our operating income margin by approximately 90 basis points and 230 basis points, respectively. The wind down of the Health Integrated business was substantially completed onDecember 31, 2019 and we do not expect to incur impairment and restructuring charges in 2020. Adjusted operating income margin for the year endedDecember 31, 2019 was 13.4% compared to 13.5% for the year endedDecember 31, 2018 .
- Diluted earnings per share for the year ended
December 31, 2019 was$1.95 compared to$1.62 for the year endedDecember 31, 2018 . During the year 2019 and 2018, we recorded impairment and restructuring charges of $8.7 million ($6.5 million net of tax) and$20.1 million ($17.0 million net of tax), respectively, related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by$0.19 and$0.49 for the year endedDecember 31, 2019 and 2018, respectively. Adjusted diluted earnings per share for the year endedDecember 31, 2019 was$3.09 compared to$2.77 for the year endedDecember 31, 2018 .
Business Highlights: Fourth Quarter 2019
- Won five new clients in the fourth quarter of 2019, including two in our operations management businesses and three in Analytics. For the full year, we won 28 new clients, 14 in operations management and 14 in Analytics.
- Recognized as a Leader in the IDC MarketScape: Worldwide Analytics for Business Operations Services 2019 Vendor Assessment
- Positioned as a Leader in the Everest Group Advanced Analytics & Insights Services PEAK Matrix™ Assessment 2020
- Recognized as a Leader in the ISG Provider Lens for Insurance BPO Digital Services –
U.S. 2019 forProperty & Casualty Insurance Services , Life & Annuity Digital Services and Life & Annuity TPA Services
Post-Fourth Quarter Highlights
- Appointed
Maurizio Nicolelli to the role of Executive Vice President, Chief Financial Officer and member of the Executive Committee
- Appointed
Vivek Jetley to the role of Executive Vice President, Head of Analytics and member of the Executive Committee
2020 Guidance
Based on current visibility, and a
- Revenue of
$1.040 billion to$1.065 billion , representing an annual revenue growth rate of 5% to 8% on a constant currency basis.
- Adjusted diluted earnings per share of
$3.42 to$3.58 .
2020 Change in Segment Reporting
Effective
Conference Call
To listen to the conference call via phone, please dial 1-877-303-6384, or if dialing internationally, 1-224-357-2191 and an operator will assist you. For those who cannot access the live broadcast, a replay will be available on the EXL website ir.exlservice.com for a period of twelve months.
About
EXL (NASDAQ: EXLS) is a leading operations management and analytics company that helps our clients build and grow sustainable businesses. By orchestrating our domain expertise, data, analytics and digital technology, we look deeper to design and manage agile, customer-centric operating models to improve global operations, drive profitability, enhance customer satisfaction, increase data-driven insights, and manage risk and compliance. Headquartered in
Continuing Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to successfully close and integrate strategic acquisitions, are discussed in more detail in EXL’s filings with the
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except share and per share amounts)
(Unaudited) | |||||||||||||||
Year ended |
Three months ended |
||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenues, net | $ | 991,346 | $ | 883,112 | $ | 256,872 | $ | 234,903 | |||||||
Cost of revenues(1) | 655,490 | 584,855 | 168,262 | 154,948 | |||||||||||
Gross profit(1) | 335,856 | 298,257 | 88,610 | 79,955 | |||||||||||
Operating expenses: | |||||||||||||||
General and administrative expenses | 126,909 | 116,202 | 33,560 | 30,592 | |||||||||||
Selling and marketing expenses | 71,842 | 63,612 | 17,846 | 18,019 | |||||||||||
Depreciation and amortization expense | 51,981 | 48,566 | 12,515 | 13,381 | |||||||||||
Impairment and restructuring charges | 8,671 | 20,056 | 1,375 | 20,056 | |||||||||||
Total operating expenses | 259,403 | 248,436 | 65,296 | 82,048 | |||||||||||
Income/(loss) from operations | 76,453 | 49,821 | 23,314 | (2,093 | ) | ||||||||||
Foreign exchange gain, net | 3,752 | 4,787 | 281 | 1,373 | |||||||||||
Interest expense | (13,612 | ) | (7,227 | ) | (2,986 | ) | (3,508 | ) | |||||||
Other income, net | 16,507 | 12,989 | 3,419 | 4,757 | |||||||||||
Income before income tax expense and earnings from equity affiliates | 83,100 | 60,370 | 24,028 | 529 | |||||||||||
Income tax expense/(benefit) | 15,172 | 3,397 | 2,601 | (3,399 | ) | ||||||||||
Income before earnings from equity affiliates | 67,928 | 56,973 | 21,427 | 3,928 | |||||||||||
Loss from equity-method investment | 269 | 247 | 71 | 71 | |||||||||||
Net income attributable to |
$ | 67,659 | $ | 56,726 | $ | 21,356 | $ | 3,857 | |||||||
Earnings per share attributable to |
|||||||||||||||
Basic | $ | 1.97 | $ | 1.65 | $ | 0.62 | $ | 0.11 | |||||||
Diluted | $ | 1.95 | $ | 1.62 | $ | 0.62 | $ | 0.11 | |||||||
Weighted-average number of shares used in computing earnings per share attributable to |
|||||||||||||||
Basic | 34,350,150 | 34,451,008 | 34,253,308 | 34,388,025 | |||||||||||
Diluted | 34,732,683 | 35,030,984 | 34,696,896 | 34,921,388 |
(1) Exclusive of depreciation and amortization.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
As of | |||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 119,165 | $ | 95,881 | |||
Short-term investments | 202,238 | 184,489 | |||||
Restricted cash | 5,453 | 5,608 | |||||
Accounts receivable, net | 171,864 | 164,752 | |||||
Prepaid expenses | 13,246 | 11,326 | |||||
Advance income tax, net | 4,698 | 9,639 | |||||
Other current assets | 24,594 | 28,240 | |||||
Total current assets | 541,258 | 499,935 | |||||
Property and equipment, net | 79,142 | 73,510 | |||||
Operating lease right-of-use assets | 86,396 | — | |||||
Restricted cash | 2,426 | 2,642 | |||||
Deferred tax assets, net | 11,855 | 6,602 | |||||
Intangible assets, net | 73,982 | 95,495 | |||||
349,529 | 349,984 | ||||||
Other assets | 36,016 | 31,015 | |||||
Investment in equity affiliate | 2,484 | 2,753 | |||||
Total assets | $ | 1,183,088 | $ | 1,061,936 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 6,564 | $ | 5,653 | |||
Current portion of long-term borrowings | 40,867 | 21,423 | |||||
Deferred revenue | 13,436 | 7,722 | |||||
Accrued employee costs | 71,626 | 54,893 | |||||
Accrued expenses and other current liabilities | 71,023 | 64,169 | |||||
Current portion of operating lease liabilities | 24,148 | — | |||||
Income taxes payable, net | 1,432 | 1,012 | |||||
Current portion of finance lease liabilities | 253 | 223 | |||||
Total current liabilities | 229,349 | 155,095 | |||||
Long-term borrowings, less current portion | 194,131 | 263,241 | |||||
Finance lease liabilities, less current portion | 430 | 315 | |||||
Income taxes payable | 1,790 | — | |||||
Deferred tax liabilities, net | 966 | 8,445 | |||||
Operating lease liabilities, less current portion | 74,709 | — | |||||
Other non-current liabilities | 11,712 | 16,521 | |||||
Total liabilities | 513,087 | 443,617 | |||||
Commitments and contingencies | |||||||
Preferred stock, |
— | — | |||||
Common stock, |
39 | 38 | |||||
Additional paid-in capital | 391,240 | 364,179 | |||||
Retained earnings | 551,903 | 484,244 | |||||
Accumulated other comprehensive loss | (84,892 | ) | (83,467 | ) | |||
Total including shares held in treasury | 858,290 | 764,994 | |||||
Less: 4,295,413 shares as of |
(188,289 | ) | (146,925 | ) | |||
Stockholders' equity | $ | 670,001 | $ | 618,069 | |||
Non-controlling interest | — | 250 | |||||
Total equity | $ | 670,001 | $ | 618,319 | |||
Total liabilities and stockholders’ equity | $ | 1,183,088 | $ | 1,061,936 |
Reconciliation of Adjusted Financial Measures to GAAP Measures
In addition to its reported operating results in accordance with
(i) Adjusted operating income and adjusted operating income margin;
(ii) Adjusted EBITDA and adjusted EBITDA margin;
(iii) Adjusted net income and adjusted diluted earnings per share; and
(iv) Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles, should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, the financial results calculated in accordance with GAAP and reconciliations from those financial statements should be carefully evaluated. EXL believes that providing these non-GAAP financial measures may help investors better understand EXL’s underlying financial performance. Management also believes that these non-GAAP financial measures, when read in conjunction with EXL’s reported results, can provide useful supplemental information for investors analyzing period-to-period comparisons of the Company’s results and comparisons of the Company’s results with the results of other companies. Additionally, management considers some of these non-GAAP financial measures to determine variable compensation of its employees. The Company believes that it is unreasonably difficult to provide its earnings per share financial guidance in accordance with GAAP for a number of reasons, including, without limitation, the Company’s inability to predict its future stock-based compensation expense under ASC Topic 718, the amortization of intangibles associated with further acquisitions and the currency fluctuations and associated tax impacts. As such, the Company presents guidance with respect to adjusted diluted earnings per share. The Company also incurs significant non-cash charges for depreciation that may not be indicative of the Company’s ability to generate cash flow.
EXL non-GAAP financial measures exclude, where applicable, stock-based compensation expense, amortization of acquisition-related intangible assets, impairment charges of acquired long-lived and intangible assets including goodwill, provision for litigation settlement, non-cash interest expense on convertible senior notes, restructuring charges and other acquisition-related expenses or benefits. Acquisition-related expenses or benefits include, changes in the fair value of earn-out consideration liabilities, external deal costs, integration expenses, direct and incremental travel costs and non-recurring benefits. In addition to excluding the above items, our adjusted net income and adjusted diluted EPS also excludes the effect of incremental income tax expense related to the
A limitation of using non-GAAP financial measures versus financial measures calculated in accordance with GAAP is that non-GAAP financial measures do not reflect all of the amounts associated with our operating results as determined in accordance with GAAP and exclude costs that are recurring, namely stock-based compensation and amortization of acquisition-related intangible assets. EXL compensates for these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP financial measures to allow investors to evaluate such non-GAAP financial measures.
The information provided on a constant currency basis reflects a comparison of current period results translated at the prior period currency rates. This information is provided because EXL believes that it provides useful comparative incremental information to investors regarding EXL’s true operating performance. EXL’s primary exchange rate exposure is with the Indian Rupee, the
The following table shows the reconciliation of these non-GAAP financial measures for the year ended
Reconciliation of Adjusted Operating Income and Adjusted EBITDA
(Amounts in thousands)
Year ended | Three months ended | |||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | ||||||||||||||||
Net income (GAAP) | $ | 67,659 | $ | 56,726 | $ | 21,356 | $ | 3,857 | $ | 19,044 | ||||||||||
add: Income tax expense/(benefit) | 15,172 | 3,397 | 2,601 | (3,399 | ) | 5,701 | ||||||||||||||
subtract: Interest expense, foreign exchange gain, net, loss from equity-method investment and other income, net | (6,378 | ) | (10,302 | ) | (643 | ) | (2,551 | ) | (2,323 | ) | ||||||||||
Income/(loss) from operations (GAAP) | $ | 76,453 | $ | 49,821 | $ | 23,314 | $ | (2,093 | ) | $ | 22,422 | |||||||||
add: Stock-based compensation expense | 26,070 | 23,901 | 4,532 | 6,590 | 7,427 | |||||||||||||||
add: Amortization of acquisition-related intangibles | 21,558 | 20,377 | 4,974 | 5,951 | 5,502 | |||||||||||||||
add: Impairment and restructuring charges (a) | 8,671 | 20,056 | 1,375 | 20,056 | 489 | |||||||||||||||
add: Provision for litigation settlement (b) | — | 2,400 | — | — | — | |||||||||||||||
add: Acquisition-related expenses (c) | — | 2,295 | — | 236 | — | |||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 132,752 | $ | 118,850 | $ | 34,195 | $ | 30,740 | $ | 35,840 | ||||||||||
Adjusted operating income margin as a % of Revenues (Non-GAAP) | 13.4 | % | 13.5 | % | 13.3 | % | 13.1 | % | 14.3 | % | ||||||||||
add: Depreciation | 30,423 | 28,189 | 7,541 | 7,430 | 7,545 | |||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ | 163,175 | $ | 147,039 | $ | 41,736 | $ | 38,170 | $ | 43,385 | ||||||||||
Adjusted EBITDA margin as a % of revenue (Non-GAAP) | 16.5 | % | 16.7 | % | 16.2 | % | 16.2 | % | 17.3 | % | ||||||||||
(a) To exclude impairment and restructuring charges related to wind down of the Health Integrated business. (b) To exclude provision for litigation settlement recorded during the three months ended (c) To exclude acquisition-related expenses. |
Reconciliation of Adjusted Net Income and Adjusted Diluted Earnings Per Share
(Amounts in thousands, except per share data)
Year ended | Three months ended | |||||||||||||||||||
2019 | 2018 | 2019 | 2018 | 2019 | ||||||||||||||||
Net income (GAAP) | $ | 67,659 | $ | 56,726 | $ | 21,356 | $ | 3,857 | $ | 19,044 | ||||||||||
add: Stock-based compensation expense | 26,070 | 23,901 | 4,532 | 6,590 | 7,427 | |||||||||||||||
add: Amortization of acquisition-related intangibles | 21,558 | 20,377 | 4,974 | 5,951 | 5,502 | |||||||||||||||
add: Impairment and restructuring charges (a) | 8,671 | 20,056 | 1,375 | 20,056 | 489 | |||||||||||||||
add: Provision for litigation settlement (b) | — | 2,400 | — | — | — | |||||||||||||||
add: Acquisition-related (benefits)/expenses (c) | (761 | ) | 1,045 | — | (1,014 | ) | (761 | ) | ||||||||||||
add: Non-cash interest expense related to convertible senior notes (d) | 2,472 | 600 | 636 | 600 | 618 | |||||||||||||||
subtract: Effect of Tax Reform Act and other non-recurring tax expenses/(benefits) (e) | (3,134 | ) | (7,810 | ) | (1,663 | ) | (2,974 | ) | — | |||||||||||
subtract: Tax impact on stock-based compensation expense (f) | (7,986 | ) | (12,101 | ) | (2,144 | ) | (2,837 | ) | (1,790 | ) | ||||||||||
subtract: Tax impact on amortization of acquisition-related intangibles | (4,621 | ) | (4,351 | ) | (1,042 | ) | (1,511 | ) | (1,188 | ) | ||||||||||
subtract: Tax impact on impairment and restructuring charges | (2,140 | ) | (3,072 | ) | (352 | ) | (3,072 | ) | (120 | ) | ||||||||||
subtract: Tax impact on provision for litigation settlement | — | (612 | ) | — | — | — | ||||||||||||||
subtract: Tax impact on acquisition-related expenses/(benefits) | 186 | (15 | ) | — | 253 | 186 | ||||||||||||||
subtract: Tax impact on non-cash interest expense related to convertible senior notes | (606 | ) | (150 | ) | (159 | ) | (150 | ) | (150 | ) | ||||||||||
Adjusted net income (Non-GAAP) | $ | 107,368 | $ | 96,994 | $ | 27,513 | $ | 25,749 | $ | 29,257 | ||||||||||
Adjusted diluted earnings per share (Non-GAAP) | $ | 3.09 | $ | 2.77 | $ | 0.79 | $ | 0.74 | $ | 0.84 |
(a) To exclude impairment and restructuring charges related to wind down of the Health Integrated business.
(b) To exclude provision for litigation settlement recorded during the three months ended
(c) To exclude acquisition related expenses and one-time benefits.
(d) To exclude non-cash interest expense related to convertible senior notes.
(e) In 2019, the Company recorded non-recurring tax benefits of
(f) Tax impact includes
Contact:
Vice President, Investor Relations
(212) 624-5913
ir@exlservice.com
Source: ExlService Holdings, Inc.